Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 55248-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#55248-1-AP, RRID:AB_10836935
- Product name
- GPR35 antibody
- Antibody type
- Polyclonal
- Description
- GPR35 antibody (Cat. #55248-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: FC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Dietary anthocyanidin pelargonidin activates G protein-coupled receptor 35.
Clinical significance of CXCL17 in cervical cancer.
Processed silkworm powder (Hongjam) ameliorates metabolic dysfunction-associated steatotic liver disease via GPR35/PKA and SIRT1/AMPK pathways.
Prognostic implications of the interaction between intratumoral microbiome and immune response in gastric cancer.
Structural and Functional Basis of G Protein-Coupled Receptor 35 Activation by Pyrroloquinoline Quinone.
Aminosalicylates target GPR35, partly contributing to the prevention of DSS-induced colitis.
Mitochondrial remodeling and ischemic protection by G protein-coupled receptor 35 agonists.
Functional metabolomics reveal the role of AHR/GPR35 mediated kynurenic acid gradient sensing in chemotherapy-induced intestinal damage.
Nakashima F, Shimomura S, Wakabayashi M, Loh WQ, Ando H, Sei H, Hattori H, Utomo DH, Kita M, Inoue A, Uchida K, Shibata T
The FEBS journal 2026 Mar;293(5):1386-1399
The FEBS journal 2026 Mar;293(5):1386-1399
Clinical significance of CXCL17 in cervical cancer.
Zhai J, Pang T, An Y, Wang J, Zhang X, Zhang L, Zhang L, Dong L
Medicine 2026 Jan 2;105(1):e46178
Medicine 2026 Jan 2;105(1):e46178
Processed silkworm powder (Hongjam) ameliorates metabolic dysfunction-associated steatotic liver disease via GPR35/PKA and SIRT1/AMPK pathways.
Lee DY, Ahn HR, Han YM, Song MY, Lee SW, Jang YK, Kim S, Go EJ, Kim EH
Frontiers in nutrition 2025;12:1727043
Frontiers in nutrition 2025;12:1727043
Prognostic implications of the interaction between intratumoral microbiome and immune response in gastric cancer.
Liu S, Qi L, Dong L, Sun W, Liu S, Li P, Zhang N
Microbiology spectrum 2025 May 6;13(5):e0283024
Microbiology spectrum 2025 May 6;13(5):e0283024
Structural and Functional Basis of G Protein-Coupled Receptor 35 Activation by Pyrroloquinoline Quinone.
Ando H, Kanamori A, Wakabayashi M, Nakashima F, Sei H, Hattori H, Kita M, Inoue A, Murakami A, Akagawa M, Uchida K, Shibata T
Biochemistry 2025 Dec 16;64(24):4758-4767
Biochemistry 2025 Dec 16;64(24):4758-4767
Aminosalicylates target GPR35, partly contributing to the prevention of DSS-induced colitis.
Otkur W, Wang J, Hou T, Liu F, Yang R, Li Y, Xiang K, Pei S, Qi H, Lin H, Zhou H, Zhang X, Piao HL, Liang X
European journal of pharmacology 2023 Jun 15;949:175719
European journal of pharmacology 2023 Jun 15;949:175719
Mitochondrial remodeling and ischemic protection by G protein-coupled receptor 35 agonists.
Wyant GA, Yu W, Doulamis IP, Nomoto RS, Saeed MY, Duignan T, McCully JD, Kaelin WG Jr
Science (New York, N.Y.) 2022 Aug 5;377(6606):621-629
Science (New York, N.Y.) 2022 Aug 5;377(6606):621-629
Functional metabolomics reveal the role of AHR/GPR35 mediated kynurenic acid gradient sensing in chemotherapy-induced intestinal damage.
Wang D, Li D, Zhang Y, Chen J, Zhang Y, Liao C, Qin S, Tian Y, Zhang Z, Xu F
Acta pharmaceutica Sinica. B 2021 Mar;11(3):763-780
Acta pharmaceutica Sinica. B 2021 Mar;11(3):763-780
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The GPR35 antibody from Proteintech is a rabbit polyclonal antibody to a peptide of human GPR35. This antibody recognizes human antigen. The GPR35 antibody has been validated for the following applications: ELISA, WB analysis.
